Cargando…
Fibrotic activity quantified in serum by measurements of type III collagen pro-peptides can be used for prognosis across different solid tumor types
Due to activation of fibroblast into cancer-associated fibroblasts, there is often an increased deposition of extracellular matrix and fibrillar collagens, e.g. type III collagen, in the tumor microenvironment (TME) that leads to tumor fibrosis (desmoplasia). Tumor fibrosis is closely associated wit...
Autores principales: | Willumsen, Nicholas, Jensen, Christina, Green, George, Nissen, Neel I., Neely, Jaclyn, Nelson, David M., Pedersen, Rasmus S., Frederiksen, Peder, Chen, Inna M., Boisen, Mogens K., Johansen, Astrid Z., Madsen, Daniel H., Svane, Inge Marie, Lipton, Allan, Leitzel, Kim, Ali, Suhail M., Erler, Janine T., Hurkmans, Daan P., Mathijssen, Ron H. J., Aerts, Joachim, Eslam, Mohammed, George, Jacob, Christiansen, Claus, Bissel, Mina J., Karsdal, Morten A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948122/ https://www.ncbi.nlm.nih.gov/pubmed/35332383 http://dx.doi.org/10.1007/s00018-022-04226-0 |
Ejemplares similares
-
Blood-based extracellular matrix biomarkers are correlated with clinical outcome after PD-1 inhibition in patients with metastatic melanoma
por: Hurkmans, Daan P, et al.
Publicado: (2020) -
Levels of type XVII collagen (BP180) ectodomain are elevated in circulation from patients with multiple cancer types and is prognostic for patients with metastatic colorectal cancer
por: Crespo-Bravo, Marina, et al.
Publicado: (2023) -
Collagens and Cancer associated fibroblasts in the reactive stroma and its relation to Cancer biology
por: Nissen, Neel I., et al.
Publicado: (2019) -
Post-translational modifications of vimentin reflect different pathological processes associated with non-small cell lung cancer and chronic obstructive pulmonary disease
por: Nissen, Neel Ingemann, et al.
Publicado: (2019) -
Prognostic value of blood-based fibrosis biomarkers in patients with metastatic colorectal cancer receiving chemotherapy and bevacizumab
por: Nissen, Neel I., et al.
Publicado: (2021)